Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura E Johnson

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Journal for Immunotherapy of Cancer|July 19, 2017
Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccinationLaura E Johnson, Brian M Olson, Douglas G McNeel
Cancer Immunology, Immunotherapy : CII|October 31, 2012
The androgen receptor: a biologically relevant vaccine target for the treatment of prostate cancerBrian M Olson, Laura E Johnson, Douglas G McNeel
Journal of Morphology|January 18, 2019
Pitch control and speed limitation during overground deceleration in lemurid primatesCharlotte E Miller, Henry Pinkard, Laura E Johnson, et al.
Current Cancer Therapy Reviews|March 4, 2014
DNA Vaccines for Prostate CancerDouglas G McNeel, Jordan T Becker, Laura E Johnson, et al.
Case Reports in Infectious Diseases|September 12, 2012
Two case reports of neuroinvasive west nile virus infection in the critical care unitEdgardo M Flores Anticona, Hadeel Zainah, Daniel R Ouellette, et al.
Urologic Oncology|December 17, 2013
Preclinical and clinical development of DNA vaccines for prostate cancerV T Colluru, Laura E Johnson, Brian M Olson, et al.
Cancer Immunology, Immunotherapy : CII|November 15, 2006
Plasmid DNA vaccine encoding prostatic acid phosphatase is effective in eliciting autologous antigen-specific CD8+ T cellsLaura E Johnson, Thomas P Frye, Nachimuthu Chinnasamy, et al.
Human Vaccines & Immunotherapeutics|August 29, 2024
Long-term follow up of patients treated with a DNA vaccine (pTVG-hp) for PSA-recurrent prostate cancerTommaso P Tonelli, Jens C Eickhoff, Laura E Johnson, et al.
Chinese Clinical Oncology|December 11, 2013
Prostate carcinoma in transgenic Lewis rats - a tumor model for evaluation of immunological treatmentsLaura E Johnson, Jordan T Becker, Jason A Dubovsky, et al.
Oncoimmunology|September 18, 2018
Heterologous vaccination targeting prostatic acid phosphatase (PAP) using DNA and Laura E Johnson, Dirk Brockstedt, Meredith Leong, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal for Immunotherapy of Cancer|July 19, 2017
Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccinationLaura E Johnson, Brian M Olson, Douglas G McNeel
Cancer Immunology, Immunotherapy : CII|October 31, 2012
The androgen receptor: a biologically relevant vaccine target for the treatment of prostate cancerBrian M Olson, Laura E Johnson, Douglas G McNeel
Journal of Morphology|January 18, 2019
Pitch control and speed limitation during overground deceleration in lemurid primatesCharlotte E Miller, Henry Pinkard, Laura E Johnson, et al.
Current Cancer Therapy Reviews|March 4, 2014
DNA Vaccines for Prostate CancerDouglas G McNeel, Jordan T Becker, Laura E Johnson, et al.
Case Reports in Infectious Diseases|September 12, 2012
Two case reports of neuroinvasive west nile virus infection in the critical care unitEdgardo M Flores Anticona, Hadeel Zainah, Daniel R Ouellette, et al.
Urologic Oncology|December 17, 2013
Preclinical and clinical development of DNA vaccines for prostate cancerV T Colluru, Laura E Johnson, Brian M Olson, et al.
Cancer Immunology, Immunotherapy : CII|November 15, 2006
Plasmid DNA vaccine encoding prostatic acid phosphatase is effective in eliciting autologous antigen-specific CD8+ T cellsLaura E Johnson, Thomas P Frye, Nachimuthu Chinnasamy, et al.
Human Vaccines & Immunotherapeutics|August 29, 2024
Long-term follow up of patients treated with a DNA vaccine (pTVG-hp) for PSA-recurrent prostate cancerTommaso P Tonelli, Jens C Eickhoff, Laura E Johnson, et al.
Chinese Clinical Oncology|December 11, 2013
Prostate carcinoma in transgenic Lewis rats - a tumor model for evaluation of immunological treatmentsLaura E Johnson, Jordan T Becker, Jason A Dubovsky, et al.
Oncoimmunology|September 18, 2018
Heterologous vaccination targeting prostatic acid phosphatase (PAP) using DNA and Laura E Johnson, Dirk Brockstedt, Meredith Leong, et al.
Pageof 5